Lv1
36 积分 2025-07-08 加入
Interleukin-17 Inhibitors and Early Major Adverse Cardiovascular Events
6个月前
已完结
Bimekizumab versus Adalimumab in Plaque Psoriasis
7个月前
已完结
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial
8个月前
已完结
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
10个月前
已完结
The association between urate‐lowering therapies and treatment‐related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta‐analysis of randomized trials
10个月前
已完结
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
10个月前
已完结
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
10个月前
已完结
Effects of Vunakizumab Treatment on Detailed Dimensions of Patient-Reported Outcomes in Moderate-to-Severe Plaque Psoriasis Patients: A Post-Hoc Analysis of a Randomized Controlled Trial (NCT04839016)
11个月前
已完结
Association of Obesity and Innate Immune Markers With Resistance to Biologic Therapy in Psoriasis
1年前
已完结
Dermoscopic changes in acquired melanocytic nevi during and after pregnancy– A Case-control Prospective Study
1年前
已关闭
皖公网安备34019202002308
